Sign In
Buy BSX
$48.85
+1.16 (+2.43%)
At Close: Jun 04, 2026
Needham Just Boosted Its Price Target on These 3 Stocks
07:05am, Thursday, 02'nd May 2024
It's not exactly an ideal time to be a stock market investor. The market is in correction territory, with many leading tech giants experiencing a pullback in prices.
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
10:34am, Tuesday, 30'th Apr 2024
Medical device maker Boston Scientific Co.'s NYSE: BDX product portfolio encompasses a wide range of therapeutic areas, from cardiovascular, urology, and neuromodulation to endoscopy instruments and r
Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year?
10:46am, Monday, 29'th Apr 2024
Here is how Boston Scientific (BSX) and Canopy Growth Corporation (CGC) have performed compared to their sector so far this year.
3 Medical Products Stocks Set to Beat This Earnings Season
12:31pm, Friday, 26'th Apr 2024
Here are three stocks, TXG, CAH and HOLX, which are expected to beat earnings estimates in the ongoing reporting cycle.
Here's Why Boston Scientific (BSX) is a Strong Momentum Stock
10:55am, Friday, 26'th Apr 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term
10:46am, Thursday, 25'th Apr 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Boston Scientific (BSX) Q1 Earnings Beat Estimates, View Raised
01:41pm, Wednesday, 24'th Apr 2024
Barring Neuromodulation, organic and operational revenues at Boston Scientific's (BSX) core business segments rise in the first quarter.
AHCO vs. BSX: Which Stock Is the Better Value Option?
12:41pm, Wednesday, 24'th Apr 2024
Investors with an interest in Medical - Products stocks have likely encountered both AdaptHealth Corp. (AHCO) and Boston Scientific (BSX). But which of these two stocks presents investors with the bet
Boston Scientific Beats Forecasts, Boosts Outlook on Booming Heart Device Sales
11:40am, Wednesday, 24'th Apr 2024
Shares of Boston Scientific (BSX) hit an all-time high Wednesday as the maker of medical equipment reported better-than-anticipated quarterly results and boosted its guidance on demand for its cardiov
Boston Scientific Corporation (BSX) Q1 2024 Earnings Call Transcript
11:15am, Wednesday, 24'th Apr 2024
Boston Scientific Corporation (NYSE:BSX ) Q1 2024 Earnings Conference Call April 24, 2024 8:00 AM ET Company Participants Jon Monson - Senior Vice President, Investor Relations Mike Mahoney - Chairman
Boston Scientific (BSX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
11:00am, Wednesday, 24'th Apr 2024
Although the revenue and EPS for Boston Scientific (BSX) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wal
Boston Scientific (BSX) Q1 Earnings and Revenues Top Estimates
08:41am, Wednesday, 24'th Apr 2024
Boston Scientific (BSX) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.47 per share a year ago.
Boston Scientific Stock Rises on More Than Just an Earnings Beat
08:30am, Wednesday, 24'th Apr 2024
The medical-device company tops first-quarter sales and profit estimates.
Boston Scientific raises annual profit forecast on strong demand for heart devices
06:40am, Wednesday, 24'th Apr 2024
Medical device maker Boston Scientific raised its annual profit forecast on Wednesday as the company banks on resilient demand for its heart devices, with post-pandemic elective surgical procedures pi
Boston Scientific's stock jumps 2.7% after earnings top estimates
06:38am, Wednesday, 24'th Apr 2024
Boston Scientific Corp.'s stock BSX, +1.43% rose 2.7% early Wednesday, after the medical tech company's first-quarter earnings beat analyst estimates. The company had net income of $495 million, or 33
